[Cardiometabolic effects of weight loss]. / Efectos cardiometabólicos de la pérdida de peso.
Aten Primaria
; 56(10): 102953, 2024 Oct.
Article
en Es
| MEDLINE
| ID: mdl-38705132
ABSTRACT
The prevalence of overweight and obesity, and, consequently, associated comorbidities, is increasing significantly worldwide. The guidelines recommend a percentage of weight loss> 5% to achieve beneficial effects on metabolic comorbidities associated with obesity. Furthermore, greater weight losses (> 10%) produce more significant improvements, and may even produce remission of some of these comorbidities. In this chapter, we review the evidence of the effect of weight loss through different strategies (lifestyle intervention, pharmacological treatment, or bariatric surgery) on the main cardiometabolic pathologies associated with excess adipose tissue (type 2 diabetes, high blood pressure, dyslipidemia, metabolic dysfunction-associated steatotic liver disease, inflammation, cardiovascular diseases, and mortality).
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedades Cardiovasculares
/
Pérdida de Peso
/
Obesidad
Límite:
Humans
Idioma:
Es
Revista:
Aten Primaria
Año:
2024
Tipo del documento:
Article
Pais de publicación:
España